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INTRODUCTION
Drug testing at the Olympic Games has been a source of debate
since its inception at the Summer Games in Mexico City in 1968.1 Vari-
ous arguments over which types of drugs to ban and whether or not
testing is a fair or effective deterrent to performance-enhancing drug use
have been brought forth.2 Few seem, however, to question the necessity
• J.D. Candidate 2007, University of Michigan Law School. I'd like to thank Professor
Lila Abu-Lughod of Columbia University and Professor Rebecca Young of Barnard
College for their guidance in developing this Article into its original form as a senior
thesis. Thanks also to Professor Rebecca Eisenberg, my good friend Rachael Ander-
sen-Watts, and the other members of the fall 2006 Student Scholarship Workshop at
Michigan for their invaluable assistance in revising this piece to its final form.
1. The procedures introduced at the 1968 Games tested only for stimulants because
assay procedures necessary to test for anabolic steroids were unavailable. Steroid use
was first tested for in the 1976 Montreal Games. R. Craig Kammerer, What is Doping
and How is it Detected?, in DOPING IN ELITE SPORT 3, 4 (Wayne Wilson & Edward
Derse eds., 2001).
2. See, e.g., David L. Black, Doping Control Testing Policies and Procedures: A Critique, in
DOPING IN ELITE SPORT, supra note 1, at 29 (discussing the problems of accuracy
and burden of proof inherent in current testing procedures); Angela J. Schneider &
Robert B. Butcher, An Ethical Analysis of Drug Testing, in DOPING IN ELITE SPORT,
supra note 1, at 129 (arguing that the invasion of privacy that results from current
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of the drug regulations in the first place3 or the underlying ideologies
that determine the content and procedures of the Anti-Doping Code.4
This Article takes a close look at the development and content of drug
testing rules in the Olympics and argues that while the International
Olympic Committee (IOC) defends its drug regulations under a rheto-
ric of fair play and equality, the current Anti-Doping Rules (Code)
police not only drug use, but also sex and gender, through centering
their prohibitions around hormones and misinformed conceptions of
the "natural," and therefore ostensibly fair, body.
The organizers of the Olympic Games have long used sex testing
(historically called gender verification) to disqualify athletes deemed to
have an unfair advantage over other competitors. In the early days of sex
testing, sex verification "tests" involved visual and manual examination of
all female competitors' genitalia by doctors.5 Beginning at the Mexico
City Games in 1968, laboratory testing for sex chromosomes became the
official method.6 While the IOC has abandoned the practice of chromo-
somal sex testing in the face of harsh criticism regarding the
discriminatory and exclusionary nature of the tests,7 drug testing regula-
tions, which base disqualification decisions largely around athletes'
hormonal levels,' have increased in scope and application and are more
staunchly supported than ever. 9 Viewed through the lens of prominent
drug testing practices, in particular out-of-competition testing, is not justified by the
harm supposedly caused to athletes and society by drug use).
3. Angela J. Schneider and Robert B. Butcher have written on the question of why drug
use should be banned in athletic competition. See Angela J. Schneider, Doping in Sport
and the Perversion Argument, in THE RELEVANCE OF THE PHILOSOPHY OF SPORT 117
(Gunter Gebauer ed., 1993); A.J. Schneider & R.B. Butcher, Why Olympic Athletes
Should Avoid the Use and Seek the Elimination of Performance-Enhancing Substances and
Practicesfrom the Olympic Games, 20 J. PHIL. SPORT 64 (1994).
4. Cf C.L. Cole, Testing for Sex or Drugs, 24 J. SPORT & Soc. ISSUES 331 (2000) (recog-
nizing the link between the IOC's suspension of chromosomal sex testing in 2000
and its essentially simultaneous declaration of a "global war on drugs," but not cri-
tiquing the content of the drug rules as gender regulating).
5. Id. at 331; Laura A. Wackwitz, Sex Testing in International Women s Athletics: A His-
tory of Silence, 5 WOMEN SPORT & PHYSICAL ACTIVITY J. 51, 51 (1996).
6. Jan Todd & Terry Todd, Significant Events in the History of Drug Testing and the
Olympic Movement: 1960-1999, in DOPING IN ELITE SPORT, supra note 1, at 65, 68-
69.
7. Cole, supra note 4, at 331; Brendan Pittaway, Olympic Bosses Suspend Sex Tests, THE
ExPREss, July 10, 1999, http://www.pfc.org.uk/node/857.
8. See discussion infra Part II.A.
9. See, e.g., Eddie Pells, IOC 2 Olympic Finals Set for Mornings, USATODAY.COM, Oct.
26, 2006, http://www.usatoday.com/sports/olympics/summer/2006-10-26-beijing-
finals_ x.htm (reporting that the number of drug tests performed in Beijing in 2008
will increase twenty-five percent over the number performed in Athens in 200 4 -a
rise from 3500 to 4500 tests); WORLD ANTI-DOPING AGENCY, INDEPENDENT OB-
[Vol. 13:207
DRUG TESTING AT OLYMPIC GAMES
feminist critiques of biological determinism, these hormonally based
drug regulations merely extend the era of exclusionary sex testing under
a new definition of legitimate "sex" that is hormonally, rather than
chromosomally, based.
Part I of this Article discusses the history and development of sex
testing and drug testing and argues that the two are both historically and
ideologically linked. Part II examines the current Code in detail and ar-
gues that the Code's focus on hormone-based controls acts to police sex
and gender in Olympic athletes, thereby extending historical sex testing
practices to a new era. This Article ultimately concludes that without
recognizing and addressing the need for further research into the role of
"sex" hormones in the body and the interplay of social context and bio-
logical circumstances, the IOC cannot maintain an anti-doping plan
that serves its fairness and equality goals.
A. Why the Olympics?
Although the IOC is an international, nongovernmental, not-for-
profit organization' ° without the power to make law as such, it operates
as part of an expansive and intricate network of regulatory bodies that
make decisions that very much affect athletes' lives, as well as public per-
ceptions of sport. IOC regulations have the force of law within the Games
themselves. Within the Olympic Games, IOC decisions are final and can
be appealed only to the IOC Executive Board or in some cases to the
Court of Arbitration for Sport (CAS)." Additionally, IOC decisions are
SERVERS (10) REPORT: XX OLYMPIC WINTER GAMES, TURIN, ITALY, 10-26 FEBRU-
ARY 2006, at 9 (2006), available at http://www.wada-ama.org/rtecontent/document/
OlympicIOReport_2006_En.pdf (reporting a forty-eight percent increase in the
number of doping tests performed at the 2006 Winter Games over the 2002 Games).
In addition to increasing the number of tests performed, the IOC has also signifi-
candy increased athletes' susceptibility to testing by providing that, as of the 2004
Games in Athens, Olympic athletes are susceptible to out-of-competition testing
"wherever in the world they [are] located" as soon as the Olympic village opens a few
weeks before the Games begin. Id.
10. INT'L OLYMPIC COMM., OLYMPIC CHARTER 26 (2004), available at http://
multimedia.olympic.org/pdf/en-report_ 122.pdf.
11. Id. The CAS is an international arbitral tribunal, developed at the instigation of for-
mer IOC President Juan Antonio Samaranch, which is designed to provide a forum
for the settlement of private disputes that arise in sport. All disputes arising in the
Olympics are subject to resolution by the IOC Executive Board. However, IOC regu-
lations in some instances provide that disputes may be settled before the CAS. The
CAS is competent to hear disputes regarding almost any aspect of the world of sport
outside the Olympic Movement, and as mentioned, in specific cases within the
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widely influential in the world of sport: drug testing in elite-level sports
competition reaches far beyond the Games themselves and is in many
cases based on the World Anti-Doping Agency's (WADA) Anti-Doping
Program, which the IOC helped to develop.12 WADA's Anti-Doping
Code, which is used in the Olympic Games, has been adopted by all of
the members of the Associations of Summer and Winter Olympic In-
ternational Federations, the IOC-recognized International Federations
in their individual capacities, and 203 National Olympic Committees.
Among others, the Commonwealth Games Federation, the International
Military Sports Council, the International Student Sports Federation,
the International World Games Association, and sixty-seven national
anti-doping organizations funded by various governments have also ac-
cepted WADA's Anti-Doping Code.1"
Drug testing in modern sports demonstrates one way that regulatory
bodies like the IOC use seemingly objective and neutral technologies of
science in ways that actually enforce and reinforce societal gender norms. I
focus on the IOC's drug testing policies in particular because the Olym-
pic Games are a widely visible and highly publicized arena where
traditional Euro-American ideals of masculinity and femininity are at
once powerfully challenged and strongly reinforced. 4 In the Olympics,
women are celebrated for exhibiting strength, power, and stamina-all
characteristics traditionally viewed as masculine. At the same time,
women are viewed with suspicion particularly because of these "mascu-
line" traits. 5
Movement. Outside the Olympic Games, the CAS often resolves contract disputes;
within the Olympic Games the IOC has empowered the CAS to hear appeals regard-
ing doping and other disciplinary disqualifications. See Matthiu Reeb, The Role and
Functions of the Court ofArbitration for Sport (CAS), in THE COURT OF ARBITRATION
FOR SPORT 1984-2004, at 31, 31-32 (Blackshaw et al. eds., 2006).
12. World Anti-Doping Agency, WADA History, http://www.wada-ama.org/en/
dynamic.ch2?pageCategory.id=253 (last visited Dec. 6, 2006).
13. World Anti-Doping Agency, Code Acceptance, http://www.wada-ama.org/en/
dynamic.ch2?pageCategory.id=270 (last visited Nov. 1, 2006).
14. See Sheila L. Cavanagh & Heather Sykes, Transsexual Bodies at the Olympics, 12 BODY
& Soc'Y 75, 83 (2006) ("mhe Olympics is a spectacle in which bodies are subject to
western imperialist scrutiny.").
15. See id. at 82-83 (recounting the stories of women who have been accused of being
men masquerading as women in Olympic competition); id. at 84 ("Genetic women
are encouraged to train their bodies to their maximum capacities but held account-
able to strict gender prototypes and conventions.").
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B. A Focus on Women and the Intersexed
In my discussion of sex, gender, and drug testing in the Olympics, I
focus heavily on the regulations' implications for women and intersexed
individuals because these are the populations that are most marginalized
by the IOC's decisions. The very participation of women in elite-level
athletics serves as a highly visible challenge to traditional notions of
femininity. Since the early days of sexology (research into sex and its
many facets), 6 a woman's interest in competing in sports caused her
femininity to become suspect and made her subject to surveillance and
regulation. In his Psychopathia Sexualis, pioneering sexologist Richard
von Krafft-Ebing notes that, "[t]he higher the anthropological develop-
ment of the race, the stronger the contrasts between man and woman."17
He also mentions the possibility of cases of "retarded sexual develop-
ment
[T]he pure type of the man or woman is often enough missed
by nature, that is to say that certain secondary male character-
istics are found in woman and vice versa, to wit, men with an
inclination for female occupations (embroidery, toilet, etc.),
and women with a decided predilection for manly sports...."
Krafft-Ebing believed that sexual differentiation, both biological and
psychological, represented a state not only of normalcy, but also of
higher evolution.' 9 For him and many other sex researchers, breaching
the gender divide behaviorally or otherwise was a sign of illness, relegat-
ing the offending individual to the status of an object of study.20
Sex testing, drug testing's adjunct and precursor, was originally in-
troduced in the Olympics to keep men from competing as women.2' Sex
testing was justified as a way of guarding against males masquerading as
16. See JANICE M. IRVINE, DISORDERS OF DESIRE 1 (2005) ("'Sexology' is an umbrella
term denoting the activity of a multidisciplinary group of researchers, clinicians, and
educators concerned with sexuality.").
17. RICHARD VON KRAFFT-EBING, PSYCHOPATHIA SEXUALIs 28 (Franklin S. Klaf trans.,
Arcade 1998) (1886).
18. Id.
19. Id.
20. See generally IRVINE, supra note 16 (describing the history of scientific sexology and its
attempts to scientifically define and engineer "normality").
21. Wackwitz, supra note 5, at 51 (citing three newspaper articles reporting that the IOC
has argued strongly for the necessity of preventing men from masquerading as women
in the Olympics).
2007]
MICHIGAN JOURNAL OF GENDER & LAW
females in competition,22 although the only documentation of a male
intentionally competing as a female in the Olympics occurred in 1936
when Hermann Ratjen of Germany bound up his genitals and took part• 23
in the women's high jump competition. (Ratjen took fourth place, be-. 24
hind three women.) Because regulators were never concerned that a
woman might attempt to enter a male competition, sex testing was
never performed on apparently male athletes. 25 Not coincidentally, the
drug testing regulations that now serve sex- and gender-policing func-
tions in place of chromosomal testing also specifically target women in
an effort to weed out athletes breaching sex and gender divides.26
In addition to, and in connection with, addressing the marginaliza-
tion of women under the current Code, this Article critiques the current
anti-doping policy's patent exclusion of intersexual individuals from
Olympic competition. Intersexed athletes powerfully challenge ideas
about the normalcy of sexual differentiation and deserve special atten-
tion here because, while there are currently procedures in place for the
admission of transsexual athletes to the Olympic Games, the IOC has
utterly failed to recognize or address intersexed athletes to date.27
22. Joe Leigh Simpson et al., Gender Verification in the Olympics, 284 JAMA 1568, 1569
(2000) ("The IOC and the International Amateur Athletic Federation (IAAF) con-
vened workshops in the late 1980s and early 1990s at which it was consistently stated
that 'the aim of gender verification tests is not to differentiate between sexes but to
prevent male impostors from participating in female competitions.' ") (quoting Arne
Ljungqvist, Gender Verification, in 8 WOMEN IN SPORT: ENCYCLOPEDIA OF SPORTS
MEDICINE 183 (Barbara L. Drinkwater ed., 2000)).
23. Joan Stephenson, Female Olympians' Sex Tests Outmoded, 276 JAMA 177, 177
(1996); see also M.A. Ferguson-Smith & Elizabeth A. Ferris, Gender Verification in
Sport: The Need for Change?, 25 BRIT. J. SPORTS MED. 17, 20 (1991) (reporting that
they know of no case where the chromosomal sex test exposed a man masquerading
as a woman).
24. Stephenson, supra note 23, at 177.
25. None of the sources cited herein mention male sex testing of any kind. See, e.g., id.;
Ferguson-Smith, supra note 23.
26. See discussion infra Part II.A.
27. Cavanagh & Sykes, supra note 14, at 87-88. Cavanagh and Sykes provide an excel-
lent critique of the IOC's recently adopted rules regarding the admission of
transsexual athletes in the Olympics. Of particular note are requirements that athletes
must have either undergone sex reassignment surgery before puberty or (1) be post-
operative (including gonadectomy where applicable), (2) have obtained legal recogni-
tion of their sex by their sponsoring country, (3) have diminished the effects of any
"gender-related advantage" through the use of hormone treatment, and (4) have lived
with their new sex for at least two years. Id. at 75-76.
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C. Sex and Gender Binaries
To understand how the IOC's anti-doping policy developed to its
current exclusionary state, it is important to examine the assumptions
about sex and gender that underlie the Code's substance and structure.
The Code's policing of traditional sex and gender boundaries arises pri-
marily because its provisions are based on the false assumptions that
(1) sex and gender are both naturally dichotomous, and (2) that sex is
unitary, encompassing biological, psychological, and behavioral elements
of identity. These assumptions lead to the belief that there are two dis-
tinct sexes underlying every outward appearance, and since gender is
based on biological sex, naturally two, and only two, distinct genders
281
also exist.
This dichotomous view emerges out of a Euro-American society
organized around a deeply entrenched binary conceptualization of sex
and gender. The idea that there are only two "true" sexes is integral to all
aspects of societal organization, and is reinforced by every institutional
structure. From the moment a baby is born in a hospital, it is assigned a
sex based on anatomical appearance. If anatomical appearance is am-
biguous, surgery will shorten a too-long clitoris or construct a vaginal
canal in order to fit the child's anatomy into the accepted "norm" for
little boys and little girls.2' In the developmental preschool years, tod-
dlers are socialized with other children of the same sex and are led down
the "girl" or "boy" toy aisles at Toys 'R' Us. Later, children go to school
and adults go to work, where locker rooms are separated by sex and
bathrooms are marked "men" and "women." The binary concept of sex
supports common ideas of healthy family structure, infuses marriage
and family law, structures medical practice and research, and most im-
portant for our purposes here, organizes sports competitions ranging
from youth tee-ball leagues to the modern-day Olympic Games. In fact,
it seems impossible to exist in this world organized around sex and gen-
der without self-identifying and being identified as either male or
female, an issue that becomes a lifelong struggle for many people.
The maintenance of this binary definition of sex and gender is de-
pendent upon the development of ideally sexed and gendered forms;
that is, the normal, healthy man versus the normal, healthy woman.
What is normal or healthy for males and females is defined at every level
28. For a disciplined discussion of the medical pathologization of intersexuality and an
accompanying critique of the "naturalness" of sex dimorphism, see SUZANNE
KESSLER, LESSONS FROM THE INTERSEXED (1998).
29. See ANNE FAUSTO-STERLING, SEXING THE BODY 45 (2000).
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of personhood: chromosomally, hormonally, physiologically, anatomi-
cally, psychologically, and behaviorally. For each of these categories, it is
easy to think of a list of characteristics that are attached to concepts of
the normal male and the normal female (for example, XY vs. XX chro-
mosomes, testosterone vs. estrogen, large muscle mass vs. high body fat,
penis vs. vagina, rational vs. emotional, aggressive vs. passive). Although
it is now accepted that there are many more than two normal and
healthy chromosomal configurations, hormonal structures, body make-
ups, anatomical appearances, and psychological or behavioral patterns,30
the Anti-Doping Code continues to pursue the maintenance of ideally
sexed and gendered forms through excluding athletes whose bodies fall
outside traditional descriptions.
In her argument for a sexual continuum, feminist biologist Anne
Fausto-Sterling offers one possible alternative to the binary conceptuali-
zation of sex and gender that is helpful in understanding the social
choices that contribute to scientific definitions. In contrast to binary
ideas of sex and gender that assume that the categories of male and fe-
male, masculine and feminine, are real and underlie all ambiguous
bodies or behaviors, Fausto-Sterling argues that choosing which criteria
to use in determining sex and gender, and choosing to make that deter-
mination in the first place, are social decisions reflecting beliefs about
gender, not about science. 2 She maintains that while the scientific and
medical communities, the most privileged sites of knowledge produc-
tion in our society, have chosen to identify only two sexes as legitimate,
there is a vast continuum of variable biological characteristics that lie
between the accepted norms for male and female.3 As is discussed in
Parts L.A and II.A, these characteristics exhibit themselves in the form of
alternate chromosomal configurations, hormonal functions in the body,
and "ambiguous" or intersexed anatomy.
Fausto-Sterling's argument for a sexual continuum is seen most
clearly in her 1993 proposal for the recognition of five sexes-an ex-
tremely provocative suggestion that normalizes and categorizes the
relatively common conditions of intersexuality that are pathologized in
scientific and medical discourse.34 Suzanne Kessler, in Lessons from the
30. See discussion infra Parts L.A, II.A.
31. See FAUSTO-STERLING, supra note 29, at 3-5.
32. Id.
33. Id. at 31.
34. Fausto-Sterling's five sexes were categorized as traditional males, traditional females,
herms ("true" hermaphrodites, possessing both an ovary and a testis), merms, and
ferms (named after "pseudo" hermaphrodites, possessing either ovaries or testes and
the "opposite" genitalia). Id. at 78-79. As Fausto-Sterling herself admits, while on the
one hand the concept of a five-sex system of categorization of human beings opens up
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Intersexed, argues that "what has primacy in everyday life is the gender
that is performed, regardless of the flesh's configuration under the
clothes."35 Kessler's arguments advocate for taking the focus away from
genitals and dispensing entirely with a separate "intersexual" identity.
For elite-level athletes, of course, the gender that is performed is
not necessarily the gender that "has primacy." Certainly engaging in
elite-level athletic competition in many ways complicates the idea of
gender performance, bringing powerful contradictions of traditional
male and female roles into the public eye. A muscular female Olympic
weightlifter, for example, challenges traditional concepts of femininity
through her appearance, and performs feats that many men will never
be strong enough to accomplish. Regardless of the weight-lifter's self-
identification as male or female, her sex and gender become suspect be-
cause of her appearance and performance level. In centering their anti-
doping provisions around biological markers of sex, IOC officials are
interested in the gender that is performed or claimed only as far as it
offers clues to the underlying "true" sex they seek. By using chromoso-
mal and hormonal tests to identify athletes as male or female, the IOC
makes the choice to prioritize minute biological elements over self-
identification much like Fausto-Sterling's five-sex system prioritizes geni-
talia.
In discussing the interplay between conceptualizations of sex and
gender, it is important to distinguish the two terms. In this Article, I use
"sex" to signify biological and physiological markers such as chromo-
somes, hormones, and anatomy, while I use "gender" to describe sexual
expression at the social level. The term "gender" specifically applies to a
person's lived sense of identity as well as their socially perceived iden-
tity.6 I use the combined term sex/gender whenever I mean to imply
that the concepts of sex and gender are being conflated. While sex and
gender are not mutually exclusive categories and each is integral to un-
derstanding the other, it is important to make a distinction between the
two levels of meaning because these categories influence the ways in
which the elite-level sports world, as well as society at large, conceptual-
izes what is natural or real versus what is unnatural or artificial.
the path to social recognition and acceptance for many intersexed persons, on the
other hand it is extremely limiting. Id.
35. KESSLER, supra note 28, at 90.
36. Eg., Jayde Pryzgoda & Joan C. Chrisler, Definitions of Gender and Sex: The Subtleties
of Meaning, 43 SEx ROLES 553, 554 (2000) (explaining that these meanings are
commonly agreed upon, although more complicated than they seem).
20071
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I. HISTORICAL AND IDEOLOGICAL LINKS BETWEEN
SEX TESTING AND DRUG TESTING
Drug testing and sex testing have shared a lengthy history and
emerged onto the Olympic scene together, demonstrating their inextri-
cable linkage in the regulation of gender in sport. The IOC's regulatory
scheme aimed at preventing "unfair advantages" in athletes taking part
in the Olympic Games has historically consisted of both drug testing
and sex testing, or in IOC terms, "gender verification."37 Both were ini-
tiated in the 1968 Games in Mexico City,38 after years of intense
concern by international sports governing bodies about the IOC's role
in maintaining a fair competition environment and discussion of possi-
ble avenues for action.39
Controversy over methods and results prompted the IOC to ex-
perimentally suspend mass sex testing in the Olympic Games," but this
should not be viewed as a victory for those who question the validity of
the idea of gender verification in sport. Sex testing on an individual ba-
sis can still take place4 and drug testing, often painted as a distinct
entity, ensures sex/gender determinations will be made in other ways.
These less conspicuous forms of sex testing prove to be even more det-
rimental to populations marginalized by Olympic regulatory procedures
than mass sex testing was because they use gender markers as motivation
to investigate sex, and base their conclusions on tenuous assumptions
about sex and the body.42
A. Sex Testing
The history of sex testing in the Olympics, viewed together with
sex testing's practical effects, demonstrates that while the IOC's sex tests
were and are performed under the rhetoric of maintaining fairness, they
37. See Todd & Todd, supra note 6, at 68-69.
38. Id.
39. Id. at 66-69 (describing the doping incidents and 1OC meetings leading to the in-
troduction of a drug testing protocol at the 1968 Games).
40. See Arne Ljungqvist, Gender Verification, in 8 WOMEN IN SPORT: ENCYCLOPEDIA OF
SPORTS MEDICINE 183, 192 (Barbara L. Drinkwater ed., 2000) (discussing the 1OC
resolution to discontinue gender verification ratified at the 109th LOC session in
Seoul, Korea, June 1999).
41. Jill Pilgrim et al., Far from the Finish Line: Transsexualism and Athletic Competition,
13 FoRDH m INTELL. PROP. MEDIA & ENT. L.J. 495, 511-12 (citing a June 5, 2001
letter from the 1OC to Jill Pilgrim, on file with the authors).
42. See discussion infra Parts L.A, II.A.
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instead have accomplished the opposite effect: chromosomal sex testing
draws sex distinctions along genetic lines that may have no correspon-
dence with perceptions of gender in the real world. The IOC's sex
testing provisions impose a particular definition of sex, one that privi-
leges genetics over other factors, on a biological continuum under which
many more than two chromosomal configurations are possible.
The IOC authorized the first laboratory sex controls at the 1968
Mexico City Games, concurrent with the first drug testing.43 The IOC
used a sex determination test based on a chromosomal definition of sex
that says that an XX chromosomal configuration constitutes a genetic
female and an XY configuration constitutes a genetic male. Until 1992,
chromosomal makeup was tested using sex-chromosome analysis of buc-
cal epithelial cells, obtained by scraping the buccal mucosa (the inside of
the cheek)." In response to criticisms of the high incidence of false-
negatives and false-positives with use of the buccal smear,45 the IOC
medical commission replaced the test with another kind of chromoso-
46
mal detector, which uses a DNA polymerase chain reaction, at the
Winter Games in Albertville, France in 1992. 47
Although the polymerase chain reaction may. be better than the
buccal smear at identifying chromosomal presence, both tests rely on a
strictly chromosomal definition of sex. These tests do not consider hor-
monal levels, physical appearance, self-identification, or any other of the
many factors that can be said to contribute to a person's sex, and cer-
tainly do not consider the role of gender in identity. Because the buccal
smear and polymerase chain reaction tests identify only chromosomal
sex, they can declare athletes to be a sex that the athletes themselves have
never identified as. Women with certain genetic disorders, such as go-
nadal dysgenesis or Androgen Insensitivity Syndrome (KS), may have
an XY chromosomal configuration, but due to their bodies' inability to
produce or to respond to testosterone, develop the genitalia, breasts, and
43. Todd & Todd, supra note 6, at 68.
44. Wackwitz, supra note 5, at 51. This test is also known as the Barr Body test since it
looks for X chromatin masses, known as "Barr Bodies," which determine excess X
chromatin (thus indicating an XX female). Id; Arne Ljungqvist & Joe Leigh Simp-
son, Medical Examination for Health of All Athletes Replacing the Need for Gender
Verification in International Sports, 267 JAMA 850, 850 (1992).
45. See Simpson et al., supra note 22, at 1569 (noting that that the polymerase chain
reaction test is technically preferable to X chromatin analysis).
46. The polymerase chain reaction test amplifies DNA extracted from a specimen and
allows detection of SRY, the gene on the Y chromosome that initiates the develop-
ment of the testis. The test identifies a person as male if SRY is present in their DNA.
Stephenson, supra note 23, at 177.
47. Simpson et al., supra note 22, at 1569.
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musculature of women." Some women with these disorders discover
their "male" chromosomal identity for the first time during a sex testing
procedure in elite-level competition.49 One striking example is found in
the case of Spanish hurdler Maria Jose Martinez Patino, who discovered
her XY chromosomal pattern for the first time at the 1985 World Uni-
versity Games. Patino was advised to fake an injury and withdraw from
the competition. ° Patino later said of her experience: "What happened
to me was like being raped. I'm sure it's the same sense of incredible
shame and violation. The only difference is that, in my case, the whole
world was watching."'"
In addition to the level of psychological discomfort this kind of dis-
covery may cause, sex tests identifying athletes as male who have lived
their entire lives as women have resulted in the disqualification of tal-
ented athletes who have committed no wrongdoing. Along with the fact
that chromosomal disorders are congenital and sometimes hereditary,
many do not offer any competitive advantage to people who have them.52
AIS, for example, disables the body's ability to utilize testosterone effec-
tively, resulting in lower muscle mass and strength." Interestingly, sex tests
that rely on chromosomal analysis fail to recognize some disorders that
might actually provide some type of advantage, such as androgen-
secreting tumors or 21-hydroxylase deficiency.
48. Stephenson, supra note 23, at 177; see also Ferguson-Smith & Ferris, supra note 23, at
18 (defining gonadal dysgenesis as a condition in which an XY female produces no
male hormones and only vestiges of the gonads are present).
49. Laura Wackwitz describes the shame and humiliation felt by women like Eva Klobu-
kowska, the first woman to "fail" an Olympic sex test, and Kirsten Wengler, a
swimmer who tested "male" poolside at a 1985 international competition, but was
later cleared. Wackwitz, supra note 5, at 51.
50. Id
51. Id. (citations omitted).
52. Stephenson, supra note 23, at 178; see also Ferguson-Smith & Ferris, supra note 23, at
18-19 (explaining that women with androgen insensitivity are not able to respond to
the testosterone their body produces or to anabolic steroids).
53. Ferguson-Smith & Ferris, supra note 23, at 18; Wackwitz, supra note 5, at 51
("[P]eople with this condition are medically not men, 'in fact, there is no advantage
because they don't have the receptors in their muscle to even benefit from male hor-
mone.'") (quoting former U.S. Olympic Committee Medical Examiner Dr. Robert
Voie) (citations omitted).
54. Stephenson, supra note 23, at 178. Cf Ferguson-Smith & Ferris, supra note 23, at 19
(explaining that while androgen-secreting tumors may lead to increased muscle mass,
it is unlikely that "such cases" would ever excel in sport).
55. Ferguson-Smith & Ferris, supra note 23, at 19. 21-hydroxylase deficiency is a condi-
tion that causes the adrenal gland to produce excess androgenic hormones, resulting
in a muscular, "male" body build. As genetic females, people with this condition pass
the chromosomal sex test. Id.
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Even where conditions that result from natural genetic variation
have the potential to result in a competitive advantage, it is problematic
to disqualify athletes on the basis of these while advantages resulting
from other genetic variations (for example, tallness that runs in one's
family) are not cause for exclusion.56 This seems especially unfair given
that sex differentiation among athletes is also surprisingly common: one
study found that one in 504 female athletes competing in selected
events, including the Olympic Games, between 1972 and 1990, was
disqualified for failing the sex chromatin test."
As mentioned earlier, although the IOC currently upholds the
chromosomal definition of sex and has used techniques like the buccal
smear and the polymerase chain reaction for over thirty years, wide-
spread controversy over the validity of making sex distinctions in this
way caused the IOC to suspend their policy of mass testing of all female
competitors at the Sydney Games in 2000.8 This suspension came as a
result of doctors and scientists declaring chromosomal testing too nar-
row and exclusive because it disqualifies athletes based on chromosomal
configurations that may not represent their claimed or even visually ap-
parent sexes.59 Further, even the newest chromosomal tests are still
known to give a significant level of false-negative and false-positive re-
suIts.
60
Although the IOC's suspension of mandatory sex testing implies
that it recognizes the problems associated with prioritizing a genetic ba-
sis for sex over other biological aspects (as well as the psychological and
sociological aspects of gender), the IOC has upheld its right to require
that a team of medical experts individually test and examine "suspect"
56. See id. at 19; Stephenson, supra note 23, at 178.
57. Ferguson-Smith & Ferris, supra, note 23, at 19. Ferguson-Smith and Ferris note that
because sex tests are in most cases conducted under conditions of strict confidential-
ity, it is difficult to determine the actual proportion of athletes who "fail" them and
to obtain data about the diagnoses of those whose sexual status is investigated. Id.
58. Ljunqvist, supra note 40, at 183.
59. E.g., Albert de la Chapelle, Why Sex Chromatin Should be Abandoned as a Screening
Method for "Gender Verification" of Female Athletes, 2 NEw STUD. ATHLETICS 49
(1986) (arguing that the sex chromatin screening method is over inclusive because it
excludes females with congenital chromosome abnormalities whose body build and
muscle strength are female in the traditional sense); Ferguson-Smith & Ferris, supra
note 23, at 17 (arguing that the sex chromatin test is more likely to exclude athletes
unfairly than to detect those who cheat); Simpson et al., supra note 22, at 1568 ("In
reality, gender verification tests are difficult, expensive, and potentially inaccurate.
Furthermore, these tests fail to exclude all potential imposters ... are discriminatory
against women with disorders of sexual development, and may have shattering conse-
quences for athletes who 'fail' a test.") (citations omitted).
60. Ljungqvist & Simpson, supra note 44, at 851.
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individuals.61 Rather than constituting a victory for women, intersexed,
or transsexual individuals, this move puts more power in the hands of
decision makers to make assumptions about sex and gender based purely
on physical characteristics or other "norms" of sex/gender ideals, such as
"male" competitiveness or aggressiveness. Under this protocol, the dis-
tinctions between sex and gender become blurred as the IOC begins to
looks for gender clues such as appearance and behavior, to justify an in-
vestigation into sex. While the IOC's individual basis for examination
does allow a majority of "traditional" or "feminine-looking" women to
avoid the testing process, groups marginalized by earlier testing proto-
cols cannot escape further scrutiny. The ideal of the world-class athlete
who is also sufficiently "feminine" is never questioned in this process.
B. Drug Testing
In light of the controversy surrounding IOC sex testing practices
and the 2000 suspension of mandatory sex testing, it becomes increas-
ingly important to examine the other ways that Olympic medical
officials and agencies police sex and gender in sports. Drug testing in the
Olympics has always functioned in conjunction with sex testing not
only in promoting the Olympic rhetoric of fair play, but also in drawing
sex and gender distinctions, defining the "natural" and the "unnatural,"
and deciding the fate of many an aspiring athlete.62 Now more than ever,
when drug testing appears more and more distant from the sex testing
woes of the past, it is important to look at the IOC's anti-doping guide-
lines and practices in terms of both their drug and sex/gender policing
roles.
The IOC adopted its first anti-doping policy at the 1964 Congress
of the IOC in Tokyo.63 The policy at this point consisted of a formal
condemnation of performance-enhancing drug use and sanctioning of
persons or national sports organizations that used or supported the use
of drugs.6  The IOC also required that individuals applying for an
61. Cole, supra note 4, at 331; Pilgrim et al., supra note 41, at 511-12 (citing a June 5,
2001 letter from the IOC to Jill Pilgrim, on file with the authors).
62. For example, during the 2004 Games in Athens, the IOC disqualified fifteen athletes
for doping or for committing anti-doping rule violations, such as unjustified unavail-
ability for testing. See Anti-Doping Rules Procedures & Violations at the Athens 2004
Olympic Games, http://multimedia.olympic.org/pdf/en-report_92l.pdf (last visited
Dec. 14, 2006). At least nine other athletes were suspended by their sport's federation
for unspecified doping violations. See id.
63. Todd & Todd, supra note 6, at 67.
64. Id.
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Olympic berth sign a pledge of non-drug use and asked that national
sports organization committees inform their athletes that they may be
subject to testing, although no testing procedures were in place at the
61time. In May of 1967, the IOC voted to adopt a drug and sex testing
policy to be implemented at the 1968 Games in Mexico City.66 At this
meeting, the IOC recognized a formal definition of "doping": "the use
of substances or techniques in any form or quantity alien or unnatural
to the body with the exclusive aim of obtaining an artificial or unfair
increase of performance in competition. ''67 Among the new banned
substances on the IOC list in 1967 were alcohol, "pep" pills (ampheta-
mines), cocaine, vasodilators, opiates, and hashish. 68
At the 1968 Games, the IOC's drug testing protocol consisted of
selecting a sport at random each morning of competition and testing ten
athletes from that sport, also chosen at random. When team sports were
selected, at least two members from each team were tested.69 While this
protocol seems comprehensive, many banned and not-yet-banned sub-
stances went undetected due to new medical technologies and drug
developments.' ° Interestingly, anabolic steroids, now the main focus of
drug testing and the center of prominent doping scandals, were not even
on the IOC's prohibited substances list in 1968, probably due to the
organization's realization of its inability to test for these drugs effec-
tively.1
The IOC officially banned anabolic steroid use in 1971, although
effective tests for the substances were not adopted until October of
1973.72 The tests, which used radioimmunoassay and mass spectrometry,
were used experimentally in several international competitions over the
next several years, but were not actually implemented in Olympic com-
petition until the Montreal Summer Games of 1976.73 At the Montreal
Games, 275 steroid tests were performed, resulting in eight disqualifica-
74tions .
Over the past thirty years, the IOC has struggled to identify per-
formance-enhancing substances and develop methods for detecting
65. Id.
66. Id. at 68.
67. Id. (citations omitted).
68. Id.
69. Id. at 69.
70. See id.
71. Id. at 69-70.
72. Id. at 72.
73. Id. at 74.
74. Id. at 75.
2007]
MICHIGAN JOURNAL OF GENDER & LAW
them in the face of growing technologies that have often allowed drug-
using competitors to evade discovery.75 One of the most striking exam-
ples of gender "confusion" and doping driving the IOC's concern about
drug use and ways to detect it was the famous East German doping
scandal of the 1970s and 1980s. During this period, the East German
government financed research into developing anabolic steroids that
could not be detected by the IOC's tests. 76 The East German Olympic
medical team then systematically administered the drugs to male and
77female swimmers and track and field athletes on the team.
As one might imagine, the public (and likely IOC officials as well)
was most disturbed by the changes in appearance and performance level
of the female competitors. The popular media became enraged by this
deliberate defiance of the IOC's rules, not only out of contempt for the
regime-style system taking place and the successful attempts to deceive
the IOC, but also out of sheer discomfort over the female athletes' cross-
ing of gender boundaries. In Faust's Gold, an account of the East
German doping scandal, author Steven Ungerleider points out the dan-
gers associated with female use of testosterone-elevating drugs:
" [P] roblems include deepening of the voice (mostly an irreversible situa-
tion), an increase in body hair on the legs, pubic hair extending to the
navel and beyond, and, more dangerously, the enlargement of the clito-
ris (clitoris-hypertrophy).,, 7s Although the health of the women taking
the drugs was obviously a concern, the tremendous discomfort with see-
ing masculine-looking women beat traditionally feminine women in
competition was likely a driving force behind the IOC's relentless pur-
suit of comprehensive drug regulations.
II. SEX/GENDER POLICING UNDER TODAY'S CODE
Today, the IOC's policies and procedures for drug regulation are set
forth in the International Olympic Committee Anti-Doping Rules. 9
75. Id. at 69-109 (documenting the IOC's struggle, from the advent of drug testing
through the late 1990s, to keep ahead of doping science that has developed masking
agents that help athletes evade detection and has discovered new methods of per-
formance enhancement that the IOC has been unaware of or unable to test for).
76. Steven Dickman, East Germany: Science in Disservice of the State, 254 ScIENcE 26, 26
(1991) (reporting that dozens of documents have been uncovered revealing that East
German scientists, working under state-sponsored "Plan 14.25," developed methods
of doping that could not be detected in international competition).
77. Id.
78. STEVEN UNGERLEIDER, FAUST'S GOLD 40 (2001).
79. The IOC Anti-Doping Rules are adopted for application in each Olympic Games. In
this analysis, I will refer to the IOC Anti-Doping Rules applicable to the 2006 Win-
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The IOC instituted drug testing procedures for the Olympics in order
to promote its notion of fairness and equal opportunity for athletes. The
IOC states in the Olympic Charter, the Olympics' governing docu-
ment,0 that a goal of the Olympic Movement is to provide "every
individual ... the possibility of practising sport ... in the Olympic
spirit, which requires mutual understanding with a spirit of friendship,
solidarity, and fair y. Presumably with an aim to preserve "fair play"
in the Olympics, the IOC helped develop and has adopted WADA's
Anti-Doping Code and International Standards regarding prohibited
substances. WADA states that the World Anti-Doping Program's goals
include "protect[ing] the Athletes' fundamental right to participate in
doping-free sport and thus promote health, fairness, and equality for
Athletes worldwide."82 While the IOC's and WADA's stated goals are
laudable, a close look at the history and makeup of the current Code
reveals that in their quest for equality and fair play, these agencies have
cultivated drug regulations that serve the same sex-policing functions
that sex testing historically has, and function to police gender by locat-
ing gender identity in the chemical and physical makeup of the body.
The most recent Code, in force for the 2006 Winter Games in Tu-
rin, Italy, consists of sixteen articles that set forth, inter alia, anti-doping
rule violations, how proof of doping is shown, the list of prohibited sub-
stances, how samples are to be analyzed, disciplinary procedures, and
sanctions. The Code prohibits several classes of substances from the
"legitimate" athlete's body, focusing on hormonal substances, but in-
cluding nonhormonal substances as well. In the Prohibited List effective
January 1, 2007, substances prohibited both in and out of competition
are broken down into the categories of Anabolic Agents, Hormones and
Related Substances, Beta-2 Agonists,84 Agents with Anti-Estrogenic Ac-
tivity, and Diuretics and other Masking Agents. s5 Substances prohibited
ter Games in Turin, Italy. INT'L OLYMPIC COMM., ANTI-DOPING RULES APPLICABLE
TO THE XX OLYMPIC WINTER GAMES IN TURIN, 2006, available at http://
multimedia.olympic.org/pdf/en-report- 1018.pdf [hereinafter 2006 CODE].
80. INT'L OLYMPIC COMM., OLYMPIC CHARTER 7 (2004), available at http://
multimedia.olympic.org/pdf/en-report_ 122.pdf.
81. Id. at 9.
82. World Anti-Doping Agency, What is the Code?, http://www.wada-ama.org/en/
dynamic.ch2?pageCategory.id=365 (last visited Oct. 25, 2006).
83. 2006 CODE §§ 2-4, 7-9.
84. Certain asthma medications are beta-2 agonists.
85. WORLD ANTI-DOPING AGENCY, THE 2007 PROHIBITED LIST INTERNATIONAL STAN-
DARD §§ S1-S5, Sept. 16, 2006 (effective Jan. 1, 2007), available at http://
ww.wada-ama.org/rtecontent/document/2007-ListEn.pdf [hereinafter 2007 PRo-
HIBITED LIST].
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only in competition include stimulants,86 narcotics s7 cannabinoids, s
and glucocorticosteroids.89 In certain sports, alcohol and beta-blockers
are also prohibited in competition. 90
A close look at the prohibited substances and what constitutes a
violation of the Code reveals that the drug testing rules are structured in
a way that excludes athletes whose bodies fall outside traditional sex and
gender norms. The Code polices sex/gender through its regulation of
athletes' hormone levels, specifically testosterone and other "sex" hor-
mones. Focusing on testosterone as the main prohibited "drug" is
problematic from a feminist perspective for several reasons. Additionally,
the focus on sex hormones more generally as definitive of maleness or
femaleness belies the historical and social construction of this category,
treating biological facts that are socially constructed as scientific (and
therefore venerated) truth. Finally, the Code's provisions for what consti-
tutes a doping violation, including its strict liability stance and limited
availability of therapeutic use exemptions, further demonstrate the
Code's disservice to women and the intersexed in elite-level sport.
A. Hormone-Based Controls
The Code polices sex and gender through its focus on hormone-
based controls, targeting most specifically testosterone and the other so-
called "sex" hormones. The focus on testosterone in particular and on
sex hormones generally is problematic for several reasons. First, the ef-
fects of testosterone in the body and its relationship to social context are
not well understood. Specifically, testosterone in the female body has
not been extensively studied, and there is evidence that physical activity
itself may affect testosterone levels in athletes of any sex. Second, basing
disqualification criteria on the relationship of testosterone to other hor-
mones in the body both prioritizes the role of the "male" hormone in
successful athletic performance and establishes a certain type of body
that is allowed to serve as the athletic ideal for persons of each sex. On a
practical level, a focus on the effects of testosterone keeps regulators on
the lookout for "masculine" female bodies.
86. These include adrenaline, amphetamine, and ephedrine. Id. § S6.
87. These include heroin, methadone, and morphine. Id. § S7.
88. These include hashish and marijuana. Id.
89. Glucocorticosteroids, also called glucocorticoids, are steroid-like compounds that
exert an anti-inflammatory effect. STEDMAN'S CONCISE MEDICAL DICTIONARY FOR
THE HEALTH PROFESSIONS 404 (John H. Dirckx ed., Illustrated 4th ed. 2001).
90. 2007 PROHIBITED LIST § P1, P2.
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The most significant classifications of prohibited substances are
based on hormone levels: Anabolic Agents, Hormones and Related Sub-
stances, and Anti-Estrogenic Agents. In the class of Anabolic Agents,
several anabolic steroids and their relatives are listed, with testosterone
and its derivatives screened on a system of ratio." A competitor is sub-
ject to further investigation if he or she exhibits a ratio of testosterone to
epitestosterone, both naturally found in male and female bodies, that is
greater than 4:1.92 Epitestosterone is a naturally occurring hormone with
a predictable relationship to testosterone when it is manufactured by the
body.9" The upper-limit ratio of 4:1 is applied to both men and women
because although men may usually have more testosterone in their bod-
ies, the relationship between testosterone and epitestosterone is
supposed to be the same in both the male and female body.94 If further
testing does not establish that an athlete's "higher than normal" ratio is
the result of a physiological or pathological condition, but is instead of
exogenous (out of the body) origin, the athlete will be disqualified from
Olympic competition and may be subject to further sanctions.95 Neither
the Prohibited List nor the Code in general defines what constitutes an
acceptable physiological or pathological condition, although the Code
does allow some prohibited substances to be used for therapeutic pur-
96
poses.
Taken by itself, it seems that the ratio system of testing for testos-
terone is a fair and non-gender-biased approach to regulating the use of
anabolic steroids and other testosterone-inducing agents in Olympic
competition. In theory, this regulation does not discriminate based on
sex, but treats all athletes equally. In reality, it is difficult to make hor-
monal regulations that apply equally to both men and women, simply
because the effects of testosterone, traditionally viewed as a "male" hor-
mone, have not been studied as extensively in women as they have in
men. 9' Ratios of testosterone to epitestosterone and appropriate measures
91. 2007 PROHIBITED LIST § Sl(1)(b).
92. Id.
93. Donald A. Berry & LeeAnn Chastain, Inferences about Testosterone Abuse among Ath-
letes, CHANcE, Spring 2004, at 5, 6.
94. See id.
95. Id
96. See discussion infra Part II.C for further discussion of the physiological or pathologi-
cal condition and therapeutic use exceptions.
97. See Berry & Chastain, supra note 93, at 6 ("Many issues associated with urinary ex-
cretion of testosterone and epitestosterone are poorly understood, especially in the
female. Research is limited and some authors have urged caution when assessing the
female T/E profile.")
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for these hormones have not been established in the bodies of healthy
98
women.
The IOC's prioritization of minute elements of biological sex over
other factors that contribute to an individual's sense of gender demon-
strates a fundamental misunderstanding of the relationship between the
biological and the social. By looking to the body to determine an indi-
vidual's gender, the IOC upholds a belief in a "natural" body that exists
prior to social context, and that tells more "truth" about gender than
lived experience can. This idea, while attractive in its simplicity, repre-
sents a gross misreading of the relationship between the body and the
outside world. It is true that biology influences social interactions, but it
is also true that social contexts directly influence biology.
Several studies have investigated the relationship between testoster-
one levels and animal or human behavior. In Myths of Gender, Anne
Fausto-Sterling presents a study of baboons that examines testosterone
levels and their relationship to social dominance. 99 The study found that
while one might traditionally expect testosterone levels to govern the
male baboons' fighting and mating activities, in reality, things worked
the other way around. Testosterone levels in male monkeys with access
to sexually receptive females sharply rose following intercourse, not be-
fore.' 0° Similarly, a male with high testosterone levels experienced a drop
in testosterone after being defeated in a fight.01 The same research group
discovered a similar effect in male humans during the Vietnam War."'
98. See id. (stating that variations in steroid profiling are associated with ethnicity, age,
sex, circadian rhythm, training and competition, diet and nutrition, menstruation,
pregnancy, common endocrine disorders like polycystic ovary syndrome, and a vari-
ety of other factors). Berry and Chastain also report on the studies of two expert
witnesses in a USA Track and Field (USATF) hearing giving rise to a later suit
brought by track and field legend Mary Decker Slaney against the International Ama-
teur Athletic Federation ([AAF). In that suit, Slaney sought review of an IAAF
arbitration panel's finding that she had committed a doping violation at the 1996
U.S. Olympic Trials in Atlanta. Expert witness Christiane Ayotte, a member of
WADA's Health and Research Committee, has reported in her research studies that
some women exhibit physiologic T/E ratios greater than 6:1. Another expert, Don H.
Catlin, Director of the Olympic Analytical Laboratory at UCLA, reported in one
study that the T/E ratio above which could not be attributed to normal physiologic
variations was 15:1. Id. (citing Slaney v. Int'l Amateur Athletic Fed'n, 244 F.3d 580
(7th Cir. 2001) (affirming the district court's application of the New York Conven-
tion on the Recognition and Enforcement of Foreign Arbitral Awards to dismiss
Slaney's claim against the IAAF)).
99. ANNE FAUSTO-STERLING, MYTHS OF GENDER 146-47 (Basic Books 2d ed. 1992)
(1985).
100. Id. at 146.
101. Id.
102. Id. at 147.
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More recently, researchers have investigated the possibility of endoge-
nous production of the anabolic steroid nandrolone in humans and have
found that intense exercise may increase its concentration in urine to
near or above allowed amounts. ' °0 Additionally, researchers posit that
genetics, trauma, hypoglycemic stress, and/or certain minerals or herbs
may contribute to increased endogenous production of nandrolone me-
tabolites .
These studies demonstrate the interaction and mutual influence of
biology and social context, as does a study quoted in an article by re-
searchers Rebecca Young and Evan Balaban, which found that "since
circulating levels of testosterone are responsive to aggression, some au-
thors conclude that 'current data supports a bidirectional model with
androgens both influencing and being influenced by aggressive behav-
ior.' ,105 The bidirectional model of influence between hormones and
behavior and experience suggests that elite-level athletes such as those
competing in the Olympic Games may have higher testosterone levels by
virtue of their athletic participation.
Imposing a ratio of testosterone in the body that is acceptable for
eligibility in athletic competition is also problematic because it desig-
nates a certain type of "normal" body that is allowed to be an athlete.
The ratio system implies that athletes whose testosterone level is below
4:1 all experience the same bodily effects of their testosterone, while ath-
letes whose levels are above 4:1 experience different effects and are either
disordered or artificially enhanced. This idea is entirely misleading.
While ratios of testosterone to epitestosterone above 4:1 may be un-
common, the average athlete's testosterone does not fall at a specific
level, but may fall anywhere within a range below 4: 1'O6 The human
body, regardless of sex, is naturally extremely variable in terms of hor-
mone levels.
In addition to the IOC's somewhat arbitrary distinction between
testosterone levels above and below 4:1, this particular regulation priori-
tizes the importance of what is traditionally viewed as a male hormone
103. R-M.N. Kohler & MI. Lambert, Urine Nandrolone Metabolites: False Positive Doping
Test?, 36 BRIT. J. SPORTS MED. 325, 326-27 (2002) (citing a study that monitored
nandrolone in professional male soccer players for two years, later published at Bruno
Le Bizec et al., Endogenous Nandrolone Metabolites in Human Urine: Preliminary Re-
sults to Discriminate between Endogenous and Exogenous Origin, 67 STEROIDS 105
(2002)).
104. Id.
105. Rebecca Young & Evan Balaban, Aggression, Biology, and Context: Deja-Vu All Over
Again?, in NEUROBIOLOGY OF AGcRESSION 191, 204 (Mark P. Mattson ed., 2003).
106. See Berry & Chastain, supra note 93, at 6.
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in successful athletic performance. While an increase in testosterone lev-
els does often lead to greater muscle mass and can lead to performance
enhancement through greater muscular strength in both men and
women, increased estrogen levels can lead to greater bone strength and
mass in both men and women as well, offering the athlete greater stam-
ina and skeletal support. 1 7 Estrogen, however, is not regulated at any
level of competition.0 8 Apparently, the effects of what is traditionally
viewed as a female hormone do not provide athletic advantages in the
eyes of the 1OC. While it may be a triumph for women on some level to
not have their estrogen levels directly regulated in the world of sport, the
omission of estrogen from the banned substance list constitutes a de-
emphasization of the active role of this hormone in creating and main-
taining the athletic body, whether male or female.
The use of the testosterone ratio in the Anti-Doping Code is more
than ideologically problematic. Setting a definitive level for the ratios of
testosterone in the "natural" body keeps IOC officials on the lookout for
individual athletes who appear as if they may have some form of un-
natural testosterone in the body. In males, anabolic steroid use can be
evidenced by large muscles, excess body hair, or a thick neck area,
among other characteristics.' 0 9 Many of the bodily characteristics af-
fected by steroid use are possible, and socially and culturally acceptable,
in males who have not used the drugs, making drug users difficult to
spot. In contrast, anabolic steroid use by women results in characteristics
that are not socially and culturally accepted as feminine, including the
same muscle growth, body and facial hair, and deeper voices that occur
in men."O Because there is a specific ideal for appearance in the female
athlete, drug testing regulations focusing on testosterone levels leave
women with high testosterone levels that result in "male" characteristics
open as targets of suspicion. This system puts the tester in a position to
discover more "truth" about the athletes than they themselves can know
and gives the tester control over not only the athlete's competitive des-
tiny, but also over knowledge production about his or her sex/gender
identity.
The Prohibited List's class of Hormones and Related Substances
also provides evidence of the sex- and gender-policing functions the cur-
107. Sundeep Khosla et al., Estrogen and the Male Skelton, 87 J. CLINICAL ENDOCRINOL-
OGY & METABOLISM 1443, 1443 (2002).
108. See 2007 PROHIBITED LIST.
109. See American College of Sports Medicine, Current Comment: Anabolic
Steroids, April 1999, http://www.acsm.org/Content/ContentFolders/Publications/
CurrentComment/ 1 999/STEROIDS.pdf.
110. Id.
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rent drug regulations perform. In this class, Chorionic Gonadotrophin
(hCG) is prohibited only in men, along with pituitary and synthetic
gonadotrophins, such as Luteinizing Hormone (LH)."' Other prohibi-
tions in this class include corticotrophins, human Growth Hormone
(hGH), insulin-like growth factors," 2 erythropoietin," 3 and insulin in
non-insulin-dependent diabetics.14 Again, athletes are subject to dis-
qualification if these substances are found in their urine in excess of
amounts deemed to be normal, unless they can prove that their exis-
tence is due to a physiological or pathological condition."5
Although hCG serves important functions in both male and female
bodies, the IOC only prohibits it in males. hCG is usually labeled a
"female" hormone because it is directly tied to reproduction in fe-
males-it is secreted in female bodies only during pregnancy and is in
fact the agent that home pregnancy tests detect."' However, hCG is also
important to male sexual development, stimulating differentiation of,
and androgen production by, the interstitial cells of the testes in utero
and influencing testicular descent. 17 The justification for the IOC's
111. LH stimulates estrogen and progesterone production from the ovary and levels vary
during the menstrual cycle. In men, LH stimulates testosterone production and con-
tributes to the maturation of spermatozoa. See David C. Aron et al., Hypothalamus &
Pituitary Gland, in BASIC & CLINICAL ENDOCRINOLOGY 106, 114 tbl.5-2 (Frances S.
Greenspan & David G. Gardner eds., 7th ed. 2004).
112. Some corticotrophin-related peptides stimulate the secretion of androgenic steroids
from the adrenal cortex. See Felix A. Conte & Melvin M. Grumbach, Abnormalities
of Sexual Determination & Differentiation, in BASIC & CLINICAL ENDOCRINOLOGY, su-
pra note 111, at 564, 589-90. Growth hormone, together with insulin-like growth
factor 1, increases protein synthesis by enhancing amino acid uptake. Aron et al., su-
pra note 111, at 121.
113. Erythropoietin is produced naturally in the body and stimulates the bone marrow to
produce red blood cells. MedlinePlus Drug Information, Epoetin (Systemic),
http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202214.html (last visited Dec.
14, 2006). Athletes use erythropoietin in an attempt to simulate high-altitude train-
ing through increasing red blood cell counts, and therefore blood oxygen levels,
which has performance-enhancing effects. See Rafael Maia de Almeida Bento et al.,
Recombinant Human Erythropoietin in Sports: A Review, 9 Rav. BsS. MED. ESPORTE
181, 184 (2003).
114. 2007 PROHIBITED LIST § S2. Insulin is prohibited in non-insulin-dependent diabetics
because athletes can use it to prevent new muscle growth from breaking down and to
increase stamina for long-distance events by enabling their muscles to store glycogen
when taken simultaneously with glucose before or between events. Andy Coghlan,
Athletes May be Increasingly Abusing Insulin, NEW SCIENTIST, Aug. 8, 2001, http://
www.newscientist.com/article.ns?id=dn 1129.
115. 2007 PROHIBITED LIST § S2.
116. See Robert N. Taylor & Dan I. Lebovic, The Endocrinology of Pregnancy, in BASIC &
CLINICAL ENDOCRINOLOGY, supra note 111, at 637, 641.
117. AHFS DRUG INFORMATION 2006, at 3066 (Gerald K. McEvoy et al. eds., 2006).
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prohibition of hCG only in men lies in the fact that hCG causes a rise
in blood testosterone levels in the male body,"8 and as discussed earlier,
testosterone is ideologically prioritized over other bodily elements in
creating the athletic body.
That hCG is not banned in nonpregnant women is further evi-
dence of the prioritization of the role of "masculinization" in
performance enhancement. If the IOC is interested in maintaining a
natural body, it seems they would be interested in banning hCG in
nonpregnant women since it does not occur naturally in those bodies.
The IOC does not explain their reason for this omission, but in light of
their emphasis on the performance-enhancing power of "masculine"
characteristics, it is likely that hCG is not banned in women simply be-
cause its effects are seen as merely "feminizing" and thus not a factor in
performance enhancement. hCG works in the female body together
with LH and Follicle Stimulating Hormone (FSH) to prepare the body
for pregnancy."9 These substances are banned only in men due to their
androgenic effects in the male body.
1 20
The third class of banned substances concerned with hormone
regulation is Agents with Anti-Estrogenic Activity.' 2' Agents with anti-
estrogenic activity, such as aromatase inhibitors, selectively inhibit the
synthesis of estrogen by limiting the conversion of androgen into estro-
gen.122 This class of substances was prohibited only in men until 2005,
but is now prohibited in both men and women. 2 1 Clearly, this regula-
tion is distinctly aimed at maintaining a "normal" balance between
hormonal elements in the body. By limiting the conversion of androgen
to estrogen, aromatase inhibitors have the ability to alter testosterone
levels in the body since more androgens will remain androgens instead
118. David J. Handelsman, The Rationale for Banning Human Chorionic Gonadotropin and
Estrogen Blockers in Sport, 91 J. CLINICAL ENDOCRINOLOGY & METABOLISM 1646
(2006) (abstract), available at http://jcem.endojournals.org/cgi/content/abstract/
91/5/1646 (last visited Dec. 15, 2006).
119. See Taylor & Lebovic, supra note 116, at 641.
120. See 2007 PROHIBITED LIST § S2.
121. 2007 PROHIBITED LIST § S4.
122. AHFS DRUG INFORMATION 2006, supra note 117, at 929. Because aromatase inhibi-
tors inhibit the conversion of androgen to estrogen, they have the effect of reducing
estrogen's effects in the body. Id. This result has been useful in the treatment of
breast cancer, and in the athletic world, is used to combat the estrogenic effects of
steroid use (e.g., gynecomastia and water retention), as well as to increase testosterone
levels. See iSteroids.com, Aromasin-Exemestane, http://www.isteroids.com/steroids/
Aromasin-Exemestane.html (last visited Dec. 16, 2006) (explaining the usefulness of
aromatase inhibitors for body building purposes to potential drug buyers).
123. See 2007 PROHIBITED LIST § S4.
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of turning into estrogen through normal biological processes.12' Thus,
like testosterone, these substances are prohibited in both men and
women because they may result in an increase in testosterone, the hor-
mone that is prioritized in the creation of the ideal athletic body. Again,
while this regulation is directed at preventing artificial performance en-
hancement, it is doing so by labeling "artificial" certain levels of
substances in the body that naturally occur in variable ranges, none of
which are proven to be any more performance enhancing than any
other.
B. The Social Construction of "Sex" Hormones
The Code regards estrogen and testosterone to be the essential ele-
ments of the makeup of female and male bodies, respectively. In
prohibiting their presence in athletes of sexes they don't "belong" to, the
IOC ideologically excludes estrogen and other "female" hormones, such
as LH and hCG, from the legitimately male body, and testosterone from
the legitimately female body. This ideology comes out of a long medical
and scientific tradition that falsely labels these hormones as specific to a
certain sex.
The idea that testosterone and estrogen are chemical messengers of
masculinity and femininity, respectively, emerged out of what Nelly
Oudshoorn refers to as a prescientific ideological linkage of masculinity
and femininity to the male and female gonads, from which sex hor-
mones were first found to be secreted.1 25 Prescientific notions are those
ideas that scientists have previous to their entrance into research, ideas
that then inform the research they conduct. Prescientific notions that
the essences of masculinity and femininity lie in the gonads date back to
the times of Aristotle, when the ovaries of female cattle were removed to
suppress sexual activity.
1 26
During the early 1930s, medical scientists interested in locating
and classifying male and female sex hormones experienced what Anne
Fausto-Sterling calls a crisis of definition.127 While earlier research (influ-
enced by prescientific notions) suggested that there was one specific
hormone that influenced female sexual development and a second, dif-
ferent hormone integral to male sexual development, in 1928, scientists
124. See AHFS DRUG INFORMATION 2006, supra note 117, at 929.
125. NELLY OUDSHOoRN, BEYOND THE NATURAL BODY 17, 19 (1994).
126. Id.
127. FAUSTO-STERLING, supra note 29, at 183.
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discovered the first evidence of the as yet unnamed "female" hormone in
the testes and urine of male animals. 28 In 1931, the first reports of the
"male" hormone appearing in female urine emerged. 29 If the hormones
now called estrogen and testosterone simultaneously appeared in both
male and female bodies (with what further research showed to be unde-
niable consistency), how could scientists, who hoped to utilize these
hormones for pharmaceutical research and various medical therapies,
define them?
In 1932, an international group of gynecologists and physiologists
met as the Health Organization of the League of Nations in London to
decide on a definition for the female sex hormone. 3 ° The female sex
hormone was classified as that hormone which has "specific oestrus-
producing activity." 31 Oestrus (estrus) is defined as "that portion or
phase of the sexual cycle of female animals characterized by willingness
to permit coitus." 32 Thus, the original definition of a hormone today so
loaded with various scientific, medical, social, and personal implications,
was derived from its reproductive function in animals, not humans.
In addition to the fact that the female sex hormone was originally
defined for its function in animal species, the original (and persistent)
definition of the hormone is flawed because of its sole focus on the
hormone's ability to induce reproductive function in females. Current
common definitions of estrogen are similarly limited to its sexual func-
tions. Estrogen is defined by Webster's dictionary as "one of several
steroid hormones produced chiefly by the ovary and responsible for the
regulation of precursors certain female reproductive functions and the
development and maintenance of female secondary sex characteris-
tics." "'3 Defining estrogen merely in terms of its sexual functions in
females is simply inaccurate and ignores the various other functions es-
trogen serves, such as promoting bone growth and stability in both
males and females.
134
The definition of the male "sex" hormone followed a similar process.
In 1935, the Second International Conference on the Standardization of
Sex Hormones was held in London.'35 At this conference, the male sex
hormone was defined as "andosterone," its unit of activity being a suffi-
128. Id. at 182.
129. Id.
130. Id. at 184.
131. Id.
132. STEDMAN'S CONCISE MEDICAL DICTIONARY FOR THE HEALTH PROFESSIONS, supra
note 89, at 336.
133. WEBSTER'S II NEW COLLEGE DICTIONARY 385 (1999).
134. Khosla et al., supra note 107, at 1443, 1447.
135. FAUSTO-STERLING, supra note 29, at 185.
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cient amount to produce a measurable size difference in the comb of a
capon (a castrated male chicken or rooster) after five days of administra-
tion. 136 So, as with the definition of the female hormone, the male
hormone was defined according to its function in animal species rather
than humans. Also like the earlier definition conference, this group's
members chose to ignore the hormone's functions that are unrelated to
sexual characteristics.
As Fausto-Sterling points out in her discussion of hormone defini-
tion, the categorization of estrogen and testosterone as sex-specific
hormones, ignoring their cross-sexual existence and other physiological
functions, leads to a subsequent sexualization of all bodily elements
(glands, organs, cells, etc.) that interact with these hormones.7 While
Oudshoorn points out that by the end of the 1930s, most sex research-
ers recognized that the male and female sex hormones were not mutually
exclusive in their occurrence and function in male and female bodies,
she also notes that male and female sex hormones were still conceptual-
ized as agents of masculinity and femininity in terms of bodily,
psychological, and behavioral characteristics. 38 Presence of the female
hormone in men was seen as an explanation for "feminine" traits and
presence of the male hormone in women was thought to explain the
existence of what were seen as "masculine" women. 139 This sexualization
of biological body elements and human characteristics clearly informs
the IOC's attitudes toward male and female bodies. Women with char-
acteristics that are traditionally associated with masculinity through their
assumed association with the male sex hormone, such as large muscle
mass or aggressive behavior, are viewed as "masculine," and are suspect
as such.
1 40
C. What Constitutes a Doping Violation
The prohibition of certain hormones and hormone levels from the
legitimate athletic body under the Code works together with the Code's
rules regarding what constitutes a doping violation to exclude athletes
with biological makeups considered to be outside of the norm. Under
the Code, drug testing is essentially a system of strict liability. The Code
136. Id.
137. Id. at 187.
138. See OUoDSHOORN, supra note 125, at 27-28.
139. Id. at 39.
140. See discussion supra, Part L.A, regarding the surveillance power of the medical com-
mission.
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states that "it is not necessary that intent, fault, negligence, or knowing
Use on the Athlete's part be demonstrated in order to establish an anti-
doping violation .... Additionally, this section provides that except
for substances the Prohibited List establishes a threshold for, "the de-
tected presence of any quantity of a Prohibited Substance or its
Metabolites or Markers in an Athlete's Sample shall constitute an anti-
doping rule violation. '1 42 This strict liability view has been upheld by the
Court of Arbitration for Sport, the tribunal that hears Code violation
appeals in the Olympic Games.'43
Holding athletes responsible for drug violations regardless of intent
or knowledge puts athletes with variable hormone levels for whatever
reason (e.g., conditions of intersexuality or increased testosterone as the
result of physical activity) in a position of guilt without the opportunity
to offer exculpatory evidence on their behalf. Thus, although the Pro-
hibited List provides that "an acceptable physiological or pathological
condition" may justify an adverse test result,144 athletes are, in reality, not
given the opportunity to present evidence of these conditions.145 Even
assuming athletes were allowed to present such evidence, the Code does
not define what it considers an acceptable physiological or pathological
condition, leaving it unclear whether athletes (and which athletes) could
actually exonerate themselves under this exception.
The Code does provide for a therapeutic use exception (TUE),
whereby athletes with a documented medical condition may apply to
use a substance in or out of competition that would normally be-prohib-
ited. 46 However, because the TUE requires that athletes notify the IOC
Medical Commission before testing, 47 this exception is of no help to
athletes who did not know of their condition before the Games. Addi-
tionally, TUEs are only granted when (1) the athlete would experience a
significant impairment to health if the prohibited substance or method
141. 2006 CODE §2.1.1.
142. 2006 CODE § 2.1.2 (emphasis added to "any," other emphasis in original).
143. Dirk-Reiner Martens, GAS Landmark Decisions, in THE COURT OF ARBITRATION FOR
SPORT 1984-2004, supra note 11, at 235-36.
144. 2007 PROHIBITED LIST § S2.
145. Martens, supra note 143, at 239 (stating that under the Code, disqualification is an
automatic and inevitable consequence of a doping violation because WADA has not
adopted principles established in CAS cases allowing athletes to provide exculpatory
evidence to rebut the presumption of guilt in suspension cases).
146. 2006 CODE § 4.3.
147. See id. at § 4.3.2 ("It is expected that most Athletes entered to compete ... who re-
quire a TUE would have already received [it] from their International Federation ...
no later than the date of the opening of the Olympic Village ... the International
Federation [must] notify the Athlete's NOC, WADA, and the IOC Medical Commis-
sion.").
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were to be withheld, (2) the therapeutic use of the substance would not
produce additional performance enhancement other than allowing the
athlete to return to a normal state of health, and (3) there is no reason-
able alternative to use of the prohibited substance or method."' It is
unclear whether the IOC would ever be willing to consider variant
hormone levels that are the result of some form of intersexuality as fal-
ling within these criteria. Given the IOC's views on what constitutes a
normal state of health, help for athletes with variant hormone levels for
whatever reason is unlikely to come in the form of a TUE.
CONCLUSION
Drug testing in the Olympic Games is a gender-policing tool that
until now has never been challenged as such. A critical look at the anti-
doping regulations and procedures of the International Olympic Com-
mittee reveals several problematic misconceptions about the human
body and its relationship to social and historical context; it treats male
and female bodies as dichotomous entities and views biology as the de-
termining force in gender identity. Further, the IOC uses drug testing to
make gender distinctions for the purposes of competition without ever
explicitly stating that this is its goal.
Given the IOC's vast misuse of science as well as the pervasive
rhetoric of "fair play" to justify its actions, it is difficult to imagine that
the current anti-doping system will soon be disrupted. However, because
Olympic sport is such a powerfully visible arena for challenging tradi-
tionally ideals of masculinity and femininity while simultaneously
working to maintain these ideals through drug testing, it is crucial that
we look to the Olympics as an even more powerful arena for change.
The IOC needs to be held responsible for the regulations that go into its
Anti-Doping Rules and should be required to research more fully the
roles of "sex" hormones in the body, specifically as they pertain to
women. Before deciding to regulate chemical substances in the body, the
IOC also needs to have a much deeper understanding of the role of so-
cial context in creating biological circumstances. In addition, the IOC
must avoid specifically targeting women through gender clues that they
see as representative of underlying masculinity. This might be accom-
plished through a more egalitarian testing system that truly chooses both
148. WORLD ANTI-DOPING AGENCY, INTERNATIONAL STANDARD FOR THERAPEUTIC USE
EXEMPTIONS § 4 (2005), available at http://www.wada-arna.orglrtecontent/document/
internationalstandard.pdf.
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male and female athletes for testing at random, along with chemical
regulations that reflect a more accurate understanding of male and fe-
male bodies.
While the focus on gender as an essential social organizer and the
policing of sex and gender in sport is disappointing to those who hope
for a more inclusive attitude toward athletic competition, hope is not
lost. Although the JOC has yet to revise or even admit to the existence
of the sex/gender policing functions of drug testing, progress has been
made in terms of the inclusion of transsexual, if not intersexed, athletes
in sport, 14 a testament to the increasing awareness of the potential for
variability in the human body. The high level of public visibility af-
forded to international athletic competitions ensures that even small
victories on this front will have lasting and widespread influence on the
world of sport. t
149. See Cavanagh & Sykes, supra note 14, at 87-88.
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